| 영문 | fracture | 한글 | 골절 |
|---|---|---|---|
| 설명 | 1. 강한 외력이 작용하여 뼈가 부분적으로 또는 완전히 이단된 상태. 큰 외력이 일시에 가해질 때는 외상성 골절. 만성적인 가압에 의할 때는 지속골절 또는 피로골절, 병적으로 조직이 침해되어 생기는 것은 병적 골절이라 한다. 골절은 긴통뼈 즉 넙다리뼈나 자뼈 등 외에 납작뼈, 즉 머리뼈 등에도 일어난다. 골절은 그 형상으로 본 선상골절-함몰골절 등과 같은 개방창을 수반하는 것을 개방골절 또는 복잡골절이라 한다. 긴통뼈의 골절은 그 골절단의 관계에서 굴절골절-전단골절-분쇄골절 등으로 구분된다. 골절의 치료는 골절단을 정위치에 접착시켜 양쪽의 골유합이 될 때까지 부동으로 고정시킨다. 긴통뼈로서 강한 근육이 부착되어 있는 부분에 골절이 생기면 이와같은 접착-고정이 쉽지 않기 때문에 여러 가지 방법이 고안-연구되어 왔다. 2. 구강외과적으로는 치아 또는 골조직의 파절이나 골절을 뜻하며, 보철영역에서는 의치나 클래스프의 파손 등을 통칭한다. |
||
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
|---|---|
| JVP | [POMD P 49 - 52] 1) Jugular Vein Pressure 2) Jugular Venous Pulse ... |
| AT III | angiotensin III; antithrombin III |
| ML | I, II, III, IV mucolipidosis I, II, III, IV |
| FS | factor of safety; Fanconi syndrome; Felty syndrome; fibromyalgia syndrome; field stimulation; Fisher... |
| A III | Angiotensin III |
|---|---|
| ANG III | Angiotensin III |
| AT III | Anti-thrombin III |
| AP III | Antipyrylazo III |
| apoLp-III | Apolipophorin III |
transverse facial vein
pseudounipolar bipolar III disorder
| Le Fort III fracture | A complex fracture in which the facial bones are separated from the cranial bones. Synonym: Le Fort III craniofacial dysjunction, Le Fort III fracture, transverse facial fracture. (05 Mar 2000) |
|---|
| Le Fort III craniofacial dysjunction | A complex fracture in which the facial bones are separated from the cranial bones. Synonym: Le Fort III craniofacial dysjunction, Le Fort III fracture, transverse facial fracture. (05 Mar 2000) |
|---|---|
| Le Fort I fracture | A fracture of the facial bones in which there is a horizontal fracture at the base of the maxillae above the apices of the teeth. Synonym: horizontal fracture, Le Fort I fracture. (05 Mar 2000) |
| Le Fort II fracture | A fracture of the midfacial skeleton with the principal fracture lines meeting at an apex at or near the superior aspect of the nasal bones. Synonym: Le Fort II fracture. (05 Mar 2000) |
| osteotomy, le fort | Transverse sectioning and repositioning of the maxilla. There are three types: le fort I osteotomy for maxillary advancement or the treatment of maxillary fractures; le fort II osteotomy for the treatment of maxillary fractures; le fort III osteotomy for the treatment of maxillary fractures with fracture of one or more facial bones. Le fort III is often used also to correct craniofacial dysostosis and related facial abnormalities. (12 Dec 1998) |
| Fort Bragg fever | A mild disease first observed among military personnel at Fort Bragg, North Carolina, characterised by fever, moderate prostration, splenomegaly, and a rash on the anterior aspects of the legs; due to the autumnalis serovar of Leptospira interrogans. Synonym: Fort Bragg fever. (05 Mar 2000) |
| Le Fort | Leon C., French surgeon and gynecologist, 1829-1893. See: Le Fort I fracture, Le Fort II fracture, Le Fort III fracture, Le Fort sound, Le Fort's amputation. (05 Mar 2000) |
| Le Fort osteotomy | An osteotomy often done to correct a maxillary skeletal deformity. Classified as Le Fort osteotomy I, II, or III, depending upon the location. (05 Mar 2000) |
| Le Fort's amputation | A modification of Pirogoff's amputation; the calcaneus is sawed through horizontally instead of vertically so that the patient steps on the same part of the heel as before. (05 Mar 2000) |
| Le Fort sound | A curved sound threaded for a filiform bougie, used for dilation of urethral strictures in the male when small caliber or presence of false passages prevents safe passage of a standard sound or catheter. (05 Mar 2000) |
| angiotensin III | <chemical> A heptapeptide formed by the enzymatic hydrolysis of angiotensin II. It has greater activity than angiotensin II for stimulating aldosterone synthesis and in the release of prostaglandins but only 20% of the pressor activity. Chemical name: Angiotensin II, 1-de-L-aspartic acid- (12 Dec 1998) |
| annexin III | <enzyme> A protein of the annexin family that catalyses the conversion of 1-d-inositol 1,2-cyclic phosphate and water to 1-d-myo-inositol 1-phosphate. Chemical name: 1-D-myo-Inositol-1,2-cyclic-phosphate 2-inositolphosphohydrolase Registry number: EC 3.1.4.36 (12 Dec 1998) |
| antithrombin III | <haematology> Antithrombin III is a protein which stimulates the removal of blood clots in the bloodstream. Small blood clots form normally within the bloodstream, but are normally dissolved via the bodys antithrombin III. Conditions that may have an associated low value of antithrombin III include: liver disease and DIC. Normal values are: 0.20 to 0.45 mg/ml or more than 50% of the laboratory control value. Conditions where there is a deficiency of this important protease inhibitor can result in a condition of hypercoagulation, resulting in an increased risk for blood clot formation. Inheritance: autosomal dominant. (13 Jan 1998) |
| apolipoprotein C-III | <biochemistry> An apolipoprotein found in VLDL, HDL, and chylomicrons. (05 Mar 2000) |
| arsenazo III | <chemical> Metallochrome indicator that changes colour when complexed to the calcium ion under physiological conditions. It is used to measure local calcium ion concentrations in vivo. Pharmacological action: dyes, indicators and reagents. Chemical name: 2,7-Naphthalenedisulfonic acid, 3,6-bis((2-arsonophenyl)azo)-4,5-dihydroxy- (12 Dec 1998) |
| arteriae intercostales posteriores III-XI | posterior intercostal arteries 3-11 |
| Le Fort III fracture |
a fracture in which the entire maxilla and one or more facial bones are completely separated from the craniofacial skeleton; such fractures are almost always accompanied by multiple fractures of the facial bones. Called also craniofacial disjunction and transverse facial f.
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|